Market Chatter: Bristol-Myers Squibb Says Patient Death Likely Unrelated to Admilparent Treatment

02:01 PM EDT, 10/12/2026 (MT Newswires) -- Bristol-Myers Squibb (BMY) said the death of a patient with idiopathic pulmonary fibrosis given a higher dose of admilparent was likely not related to the treatment, Bloomberg reported Monday, citing a company spokesperson. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.) Price: 57.02, Change: -2.10, Percent Change: -3.55